Mazdutide research compound — dual GLP-1/glucagon receptor agonist for advanced metabolic pathway studies.

Mazdutide (IBI362) is a dual GLP-1/glucagon receptor agonist research compound. By engaging both receptors, it represents a different dual-agonist approach compared to GLP-1/GIP compounds.
Mazdutide combines GLP-1 receptor activation (insulin secretion, satiety) with controlled glucagon receptor activation (lipolysis, energy expenditure). Research investigates the balance between these opposing-but-complementary pathways.
Used in research on: GLP-1/glucagon dual signaling, comparative dual agonist studies, hepatic lipid research, energy expenditure mechanisms.
| Compound | Mazdutide |
| Available Strengths | 5mg, 10mg |
| Purity | ≥99% (verified by HPLC) |
| Form | Lyophilized powder |
| Storage | -20°C, protected from light |
| Reconstitution | Bacteriostatic water (sold separately) |
| Shelf Life | 36 months (lyophilized, properly stored) |
| Certificate of Analysis | Available upon request — contact us |
Add bacteriostatic water slowly. Use within 28 days.
Lyophilized: -20°C. Reconstituted: 2-8°C.
For research use only. Not for human consumption.